U.S., Europe oppose Israeli bill on intellectual property rights

09/13/2004 | Jerusalem Post (free registration), The

The U.S. and several European countries object to an intellectual property rights bill likely to be approved by the Israeli government. The measure would only provide marketing exclusivity for pharmaceutical firms, but not protect confidentiality of proprietary tests and clinical data used to register a drug, thus allowing Israeli generic firms to produce drug copies. The issue prompted representatives of Germany, France, Denmark and Switzerland to express concern over Israel's unwillingness to honor European trade agreements.

View Full Article in:

Jerusalem Post (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health